-
1
-
-
0001962932
-
Opioid analgesics
-
Hardman JG, Limbrid LE, Gilman AG, editors, 10th ed. New York: McGraw-Hill
-
Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbrid LE, Gilman AG, editors. Goodman & Gilman's The pharmacologic basis of therapeutics. 10th ed. New York: McGraw-Hill, 2001: 569-619
-
(2001)
Goodman & Gilman's The pharmacologic basis of therapeutics
, pp. 569-619
-
-
Gutstein, H.B.1
Akil, H.2
-
2
-
-
33645325108
-
Fentanyl effervescent buccal tablets: Enhanced buccal absorption
-
Durfee S, Messina J, Khankari R. Fentanyl effervescent buccal tablets: enhanced buccal absorption. Am J Drug Deliv 2006; (1): 1-5
-
(2006)
Am J Drug Deliv
, vol.1
, pp. 1-5
-
-
Durfee, S.1
Messina, J.2
Khankari, R.3
-
4
-
-
0032899247
-
Breakthrough pain: Characteristics and impact in patients with cancer pain
-
May;
-
Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999 May; 81 (1-2): 129-34
-
(1999)
Pain
, vol.81
, Issue.1-2
, pp. 129-134
-
-
Portenoy, R.K.1
Payne, D.2
Jacobsen, P.3
-
5
-
-
34948821962
-
Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain: A double-blind, randomized, placebo-controlled study
-
Jul-Aug;
-
Slatkin NE, Xie F, Messina J, et al. Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain: a double-blind, randomized, placebo-controlled study. J Support Oncol 2007 Jul-Aug; 5 (7): 327-34
-
(2007)
J Support Oncol
, vol.5
, Issue.7
, pp. 327-334
-
-
Slatkin, N.E.1
Xie, F.2
Messina, J.3
-
6
-
-
33750322229
-
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer
-
Nov-Dec;
-
Portenoy RK, Taylor D, Messina J, et al. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. Clin J Pain 2006 Nov-Dec; 22 (9): 805-11
-
(2006)
Clin J Pain
, vol.22
, Issue.9
, pp. 805-811
-
-
Portenoy, R.K.1
Taylor, D.2
Messina, J.3
-
7
-
-
0031597891
-
Buccal mucosa as a route for systemic drug delivery: A review
-
Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci 1998; 1: 15-30
-
(1998)
J Pharm Pharm Sci
, vol.1
, pp. 15-30
-
-
Shojaei, A.H.1
-
8
-
-
29244454227
-
Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers
-
Darwish M, Tempero K, Kirby M, et al. Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers. Clin Pharmacokinet 2005; 44 (12): 1279-86
-
(2005)
Clin Pharmacokinet
, vol.44
, Issue.12
, pp. 1279-1286
-
-
Darwish, M.1
Tempero, K.2
Kirby, M.3
-
9
-
-
33745972464
-
-
Darwish M, Kirby M, Robertson Jr P, et al. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400 and 800 μg in healthy adult volunteers. Clin Ther 2006 May; 28 (5): 707-14
-
Darwish M, Kirby M, Robertson Jr P, et al. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400 and 800 μg in healthy adult volunteers. Clin Ther 2006 May; 28 (5): 707-14
-
-
-
-
10
-
-
33845766668
-
Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers
-
Jan;
-
Darwish M, Kirby M, Robertson Jr P, et al. Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers. J Clin Pharmacol 2007 Jan; 47 (1): 56-63
-
(2007)
J Clin Pharmacol
, vol.47
, Issue.1
, pp. 56-63
-
-
Darwish, M.1
Kirby, M.2
Robertson Jr, P.3
-
11
-
-
0000722192
-
Noncompartmental analysis based on statistical moment theory
-
Gibaldi M, Perrier D, editors, 2nd ed. New York: Marcel Dekker Inc
-
Gibaldi M, Perrier D. Noncompartmental analysis based on statistical moment theory. In: Gibaldi M, Perrier D, editors. Pharmacokinetics. 2nd ed. New York: Marcel Dekker Inc., 1982: 409-17
-
(1982)
Pharmacokinetics
, pp. 409-417
-
-
Gibaldi, M.1
Perrier, D.2
-
12
-
-
33746799704
-
Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics
-
Darwish M, Kirby M, Robertson P, et al. Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics. Clin Pharmacokinet 2006; 45 (8): 843-50
-
(2006)
Clin Pharmacokinet
, vol.45
, Issue.8
, pp. 843-850
-
-
Darwish, M.1
Kirby, M.2
Robertson, P.3
-
13
-
-
34548605294
-
Effect of buccal dwell time on the pharmacokinetic profile of fentanyl buccal tablet
-
Sep;
-
Darwish M, Kirby M, Jiang JG. Effect of buccal dwell time on the pharmacokinetic profile of fentanyl buccal tablet. Expert Opin Pharmacother 2007 Sep; 8 (13): 2011-6
-
(2007)
Expert Opin Pharmacother
, vol.8
, Issue.13
, pp. 2011-2016
-
-
Darwish, M.1
Kirby, M.2
Jiang, J.G.3
-
14
-
-
33746849278
-
Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 μg versus oral transmucosal fentanyl citrate 1600 μg and dose proportionality of FEBT 270 to 1300 μg: A single-dose, randomized, open-label, three-period study in healthy adult volunteers
-
May;
-
Darwish M, Tempero K, Kirby M, et al. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 μg versus oral transmucosal fentanyl citrate 1600 μg and dose proportionality of FEBT 270 to 1300 μg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers. Clin Ther 2006 May; 28 (5): 715-24
-
(2006)
Clin Ther
, vol.28
, Issue.5
, pp. 715-724
-
-
Darwish, M.1
Tempero, K.2
Kirby, M.3
|